These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3809382)

  • 21. Inert placebo versus active medication. Patient blindability in clinical pharmacological trials.
    Bystritsky A; Waikar SV
    J Nerv Ment Dis; 1994 Sep; 182(9):485-7. PubMed ID: 8083675
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trazodone and priapism.
    Scher M; Krieger JN; Juergens S
    Am J Psychiatry; 1983 Oct; 140(10):1362-3. PubMed ID: 6624973
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Two more cases of trazodone-related syncope in the elderly.
    Nambudiri DE; Mirchandani IC; Young RC
    J Geriatr Psychiatry Neurol; 1989; 2(4):225. PubMed ID: 2635019
    [No Abstract]   [Full Text] [Related]  

  • 24. Effectiveness of Low-Dose Aripiprazole Monotherapy in the Treatment for an Adolescent With Obsessive-Compulsive Disorder.
    Sertdemir M; Akça ÖF
    Clin Neuropharmacol; 2017; 40(5):236-237. PubMed ID: 28922290
    [No Abstract]   [Full Text] [Related]  

  • 25. Off-Label Trazodone Prescription: Evidence, Benefits and Risks.
    Bossini L; Coluccia A; Casolaro I; Benbow J; Amodeo G; De Giorgi R; Fagiolini A
    Curr Pharm Des; 2015; 21(23):3343-51. PubMed ID: 26088119
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peripheral edema associated with trazodone: a report of ten cases.
    Barrnett J; Frances A; Kocsis J; Brown R; Mann JJ
    J Clin Psychopharmacol; 1985 Jun; 5(3):161-4. PubMed ID: 3998206
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fluoxetine in obsessive compulsive disorder in adolescents.
    Bouvard M; Dugas M
    Int Clin Psychopharmacol; 1993; 8(4):307-10. PubMed ID: 8277152
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment of depersonalization with serotonin reuptake blockers.
    Hollander E; Liebowitz MR; DeCaria C; Fairbanks J; Fallon B; Klein DF
    J Clin Psychopharmacol; 1990 Jun; 10(3):200-3. PubMed ID: 2115893
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness of paroxetine in the treatment of obsessive-compulsive disorders.
    Kamijima K; Aoki M
    Expert Rev Neurother; 2006 Jul; 6(7):945-56. PubMed ID: 16831110
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A double-blind study to compare trazodone with amitriptyline in depressed patients.
    Carney PA; Healy D; Leonard BE
    Psychopathology; 1984; 17 Suppl 2():37-8. PubMed ID: 6371877
    [No Abstract]   [Full Text] [Related]  

  • 31. A placebo-controlled study of trazodone in bulimia nervosa.
    Pope HG; Keck PE; McElroy SL; Hudson JI
    J Clin Psychopharmacol; 1989 Aug; 9(4):254-9. PubMed ID: 2671058
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Topiramate augmentation in treatment-resistant obsessive-compulsive disorder].
    Vinkers DJ; van der Wee NJ
    Tijdschr Psychiatr; 2008; 50(11):747-50. PubMed ID: 18991236
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-dose paroxetine treatment for an adolescent with obsessive-compulsive disorder comorbid with Asperger's disorder.
    Sasayama D; Sugiyama N; Imai J; Hayashida A; Harada Y; Amano N
    Psychiatry Clin Neurosci; 2009 Apr; 63(2):251. PubMed ID: 19335398
    [No Abstract]   [Full Text] [Related]  

  • 34. Buspirone in obsessive-compulsive disorder.
    Watts VS; Neill JR
    Am J Psychiatry; 1988 Dec; 145(12):1606. PubMed ID: 3195684
    [No Abstract]   [Full Text] [Related]  

  • 35. A predictive study of obsessive-compulsive disorder response to clomipramine.
    Alarcon RD; Libb JW; Spitler D
    J Clin Psychopharmacol; 1993 Jun; 13(3):210-3. PubMed ID: 8354737
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of imipramine on depression and obsessive-compulsive symptoms.
    Foa EB; Steketee G; Kozak MJ; Dugger D
    Psychiatry Res; 1987 Jun; 21(2):123-36. PubMed ID: 3615688
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Progestin treatment for obsessive-compulsive disorder.
    Perciaccante M; Perciaccante RG
    Psychosomatics; 1993; 34(3):284-5. PubMed ID: 8493315
    [No Abstract]   [Full Text] [Related]  

  • 38. Lack of efficacy of low doses of quetiapine addition in refractory obsessive-compulsive disorder.
    Sevincok L; Topuz A
    J Clin Psychopharmacol; 2003 Oct; 23(5):448-50. PubMed ID: 14520120
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Local cerebral glucose metabolic rates in obsessive-compulsive disorder. A comparison with rates in unipolar depression and in normal controls.
    Baxter LR; Phelps ME; Mazziotta JC; Guze BH; Schwartz JM; Selin CE
    Arch Gen Psychiatry; 1987 Mar; 44(3):211-8. PubMed ID: 3493749
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Paranoid and aggressive behavior in two obsessive-compulsive adolescents treated with clomipramine.
    Alarcon RD; Johnson BR; Lucas JP
    J Am Acad Child Adolesc Psychiatry; 1991 Nov; 30(6):999-1002. PubMed ID: 1757451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.